<DOC>
	<DOCNO>NCT00650780</DOCNO>
	<brief_summary>We complete randomize , clinical trial 100,000 IU Vitamin D3 give single dose begin winter . We find wide range response dose . This study propose genetic difference account variation response 25 ( OH ) D level treatment oral Vitamin D .</brief_summary>
	<brief_title>Vitamin D Binding Protein ( Gc ) Allele Variation Effects Response Vitamin D Treatment</brief_title>
	<detailed_description>We suspect wide range response effect factor variation Vitamin D bind protein ( major transporter Vitamin D metabolites ) . Gc , also know Vitamin D bind protein ( DBP ) , group specific component , Gc globulin , 52-58 kDa multifunctional plasma protein , synthesize liver . The gene encode Gc locate chromosome 4 , three common co-dominant allele give rise three phenotype ( Gc1s , Gc1f , Gc2 ) . Gc bind actin , recruit neutrophil leukocyte convert macrophage- osteoclast- activating factor . It also major transporter Vitamin D ' metabolite . Lauridsen et al . show Gc phenotype correlate 25 ( OH ) D level group postmenopausal woman . This study propose Gc phenotype account variation response 25 ( OH ) D level treatment oral Vitamin D .</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Must willing participate additional blood draw . Must previous study . Will eligible part previous study</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Viatmin D , 25-hydroxyvitamin D , Vitamin D bind protein</keyword>
</DOC>